Funding Announcements

"We are delighted to complete a further funding round with investors who share our vision. It provides a really meaningful opportunity to capitalise on the growth opportunities emerging as the world of work continues to see accelerated change."

"It is brilliant to receive further backing from such esteemed business leaders, most notably during what has been an incredibly tough year for certain sectors. This investment comes at a crucial stage of our journey. The valued support and investment from new and existing investors will allow us to continue our rapid expansion at a time when we are moving towards a more international model. It’s great to see business leaders investing in the luxury resale market, as we move to a more sustainable and conscious way of living, as well as supporting circular fashion which people are buying into increasingly."

"The microbiome is a megatrend that is evolving very quickly, and we are the forefront of associated discovery with our unique solution to address the enterprise data challenge. We have our sights set too on other complex data challenges including CRISPR and quantum biological challenges, such as understanding the immune response more fully. The potential is phenomenal, and we are immensely grateful to our supporters for sharing our vision and helping us to scale at this pivotal time."

"Closing a significant Series A round, during these uncertain times, further validates Ori’s disruptive approach to fully automating cell and gene therapy manufacturing to increase throughput, improve quality, and decrease costs,"

"We are building a new kind of healthcare company that gives men simple and accessible solutions for their health and wellbeing problems,"